The omicron variant of the SARS-CoV-2 virus, discovered just a few weeks ago, is poised to dominate key antibody treatments in the first tests, according to an article published in the Nature British journal.»
The omicron variant of the SARS-CoV-2 virus, discovered just a few weeks ago, is poised to dominate key antibody treatments in the first tests, according to an article published in the Nature British journal.»